Phase 2 Malignant Digestive System Neoplasm Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy
Malignant Digestive System Neoplasm
Mayo Clinic60 enrolled1 locationNCT07456852
Recruiting
Phase 2
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
Malignant Female Reproductive System NeoplasmMalignant Digestive System Neoplasm
Mayo Clinic34 enrolled1 locationNCT06855524
Recruiting
Phase 2
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
Malignant Digestive System Neoplasm
Emory University60 enrolled3 locationsNCT03800693